A stratified approach to tuberculosis treatment.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. A systematic review of endpoint definitions in late phase pulmonary tuberculosis therapeutic trials.Trials · 2021
   Pooled it
2. Bridging science and policy in tuberculosis treatment through innovations in precision medicine, drug development, and cohort research: a narrative review.Ewha medical journal · 2025
   Review
3. Target regimen profiles for tuberculosis treatment.Bulletin of the World Health Organization · 2024
   Article
4. Evaluating tuberculosis treatment outcomes in Haiti from 2018 to 2019: A competing risk analysis.IJID regions · 2024
   Article
5. Recent Insights into the Structure and Function of Mycobacterial Membrane Proteins Facilitated by Cryo-EM.The Journal of membrane biology · 2021
   Review
6. Should treatment of low-level rifampicin mono-resistant tuberculosis be different?Journal of clinical tuberculosis and other mycobacterial diseases · 2021
   Article
7. Predictors of unfavorable responses to therapy in rifampicin-sensitive pulmonary tuberculosis using an integrated approach of radiological presentation and sputum mycobacterial burden.PloS one · 2021
   Article
8. Predictors of slow clinical response and extended treatment in patients with extra-pulmonary tuberculosis in Pakistan, A hospital-based prospective study.PloS one · 2021
   Article
9. Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape.PLoS medicine · 2019
   Review

Corrections and comments

• Comment on
  A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis.2018

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as